IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cyclacel Pharmaceuticals Inc

CUSIP: 23254L207 | 11 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

VSM Wealth Advisory, LLC1,882
0.0% of portfolio›$1.6K
StyleTurnoverLocationFiled
VSM Wealth Advisory, LLC
1,882$1.6K0.0%ETFMediumHunt Valley, MD2026-07-23